George Sgouros

Medicine & Life Sciences

1. Radiopharmaceuticals 100%
2. Radioisotopes 94%
3. Radioimmunotherapy 72%
4. Neoplasms 54%
5. Alpha Particles 50%
6. Radiation 41%
7. Single-Photon Emission-Computed Tomography 41%
8. Antibodies 41%
9. Therapeutics 37%
10. Bone Marrow 37%
11. Radiometry 32%
12. Prostate-Specific Antigen 29%
13. Kidney 27%
14. Liposomes 26%
15. Nuclear Medicine 25%
16. Thyroid Neoplasms 24%
17. Pharmacokinetics 22%
18. Technetium Tc 99m Dimercaptosuccinic Acid 22%
19. Prostatic Neoplasms 21%
20. Electrons 20%
21. Photons 20%
22. Relative Biological Effectiveness 19%
23. Pamphlets 19%
24. Pediatrics 19%
25. Monoclonal Antibodies 18%
26. Radioactivity 17%
27. Breast Neoplasms 17%
28. Single Photon Emission Computed Tomography Computed Tomography 16%
29. Membranes 16%
30. Radiotherapy 15%
31. Actinium-225 15%
32. Liver 14%
33. Radiobiology 14%
34. Positron-Emission Tomography 13%
35. ibritumomab tiuxetan 13%
36. Linear Energy Transfer 13%
37. 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 12%
38. Neoplasm Metastasis 11%
39. Osteosarcoma 11%
40. lintuzumab 10%
41. Software 10%
42. Non-Hodgkin's Lymphoma 10%
43. Half-Life 10%
44. monoclonal antibody M195 9%
45. Fluorodeoxyglucose F18 9%
46. Spleen 9%
47. Nude Mice 9%
48. Heterografts 9%
49. N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine 9%